Kieran is the lead analyst for Beacon DDR. He has a MSc in Cancer Cell Biology from the University of Sussex. During his research, he investigated therapeutics for glioblastoma multiforme and novel interactions for human PrimPol – a DNA damage tolerance pathway, working with a leading expert in the field of Genome Damage & Stability.